ey0015.1-9 | New clinical investigation | ESPEYB15
YM Chan , MF Lippincott , TO Kusa , SB Seminara
ey0016.6-10 | Ethical Aspects | ESPEYB16
DA Diamond , J Swartz , A Tishelman , J Johnson , YM Chan
ey0016.12-10 | Metabolic Syndrome | ESPEYB16
KJ Chan , JJ Liang , D Jolly , JD Weinand , JD Safer
ey0017.9-4 | Fertility-Related Issues | ESPEYB17
H Beaud , O Albert , B Robaire , MC Rousseau , PTK Chan , G Delbes
ey0021.12-3 | Concerns in T2D | ESPEYB21
MM Barker , MJ Davies , JA Sargeant , JCN Chan , EW Gregg , S Shabnam , K Khunti , F Zaccardi
ey0019.10-11 | Complications and comorbidities | ESPEYB19
DW Allen , G Liew , YH Cho , A Pryke , J Cusumano , S Hing , AK Chan , ME Craig , KC Donaghue
ey0017.7-4 | Clinical Guidance | ESPEYB17
YM Chan , MF Lippincott , P Sales Barroso , C Alleyn , J Brodsky , H Granados , SA Roberts , C Sandler , A Srivatsa , SB Seminara
ey0020.4-11 | Psychological Effects of Hormone Treatments | ESPEYB20
D Chen , J Berona , YM Chan , D Ehrensaft , R Garofalo , MA Hidalgo , SM Rosenthal , AC Tishelman , J Olson-Kennedy
ey0018.13-7 | Endocrinology | ESPEYB18
K Armstrong , AB Yap , S Chan-Cua , ME Craig , C Cole , V Chi Dung , J Hansen , M Ibrahim , H Nadeem , A Pulungan , J Raza , A Utari , P. Ward
ey0019.8-8 | Clinical Trials – New Treatments | ESPEYB19
AR Auchus , K Sarafoglou , PY Fechner , MG Vogiatzi , EA Imel , SM Davis , N Giri , J Sturgeon , E Roberts , JL Chan , RH Farber